Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

Patient-Reported Outcome Measures May Add Value in Breast Cancer Surgery.

Lagendijk M, van Egdom LSE, van Veen FEE, Vos EL, Mureau MAM, van Leeuwen N, Hazelzet JA, Lingsma HF, Koppert LB.

Ann Surg Oncol. 2018 Nov;25(12):3563-3571. doi: 10.1245/s10434-018-6729-6. Epub 2018 Sep 3.

PMID:
30178391
2.

The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosis.

Whitfield MG, Warren RM, Mathys V, Scott L, De Vos E, Stevens W, Streicher EM, Groenen G, Sirgel FA, Van Rie A.

J Antimicrob Chemother. 2018 Oct 1;73(10):2667-2674. doi: 10.1093/jac/dky248.

PMID:
29982641
3.

Strokes, cholesterol and statins: When mortality is an endpoint.

Vos E, Biron P.

Atherosclerosis. 2018 Aug;275:450. doi: 10.1016/j.atherosclerosis.2018.04.035. Epub 2018 May 3. No abstract available.

PMID:
29764697
4.

Dynamic Tunneling Junctions at the Atomic Intersection of Two Twisted Graphene Edges.

Bellunato A, Vrbica SD, Sabater C, de Vos EW, Fermin R, Kanneworff KN, Galli F, van Ruitenbeek JM, Schneider GF.

Nano Lett. 2018 Apr 11;18(4):2505-2510. doi: 10.1021/acs.nanolett.8b00171. Epub 2018 Mar 12.

5.

Level of agreement between laboratory and point-of-care prothrombin time in patients after stopping or continuation of acenocoumarol anticoagulation: A comparison of diagnostic accuracy.

de Vos EAJ, Hagen YJ, Meesters MI, Osmanovic N, Boer C, de Leeuw MA.

Eur J Anaesthesiol. 2018 Aug;35(8):621-626. doi: 10.1097/EJA.0000000000000786.

PMID:
29474346
6.

Evaluation of cosmetic outcome following breast-conserving therapy in trials: panel versus digitalized analysis and the role of PROMs.

Lagendijk M, Vos EL, Nieboer D, Verhoef C, Corten EML, Koppert LB.

Breast J. 2018 Jul;24(4):519-525. doi: 10.1111/tbj.12980. Epub 2018 Jan 8.

PMID:
29316049
7.

Breast and Tumour Volume Measurements in Breast Cancer Patients Using 3-D Automated Breast Volume Scanner Images.

Lagendijk M, Vos EL, Ramlakhan KP, Verhoef C, Koning AHJ, van Lankeren W, Koppert LB.

World J Surg. 2018 Jul;42(7):2087-2093. doi: 10.1007/s00268-017-4432-6.

8.

A preliminary prediction model for potentially guiding patient choices between breast conserving surgery and mastectomy in early breast cancer patients; a Dutch experience.

Vos E, Koppert L, van Lankeren W, Verhoef C, Koerkamp BG, Hunink M.

Qual Life Res. 2018 Feb;27(2):545-553. doi: 10.1007/s11136-017-1740-0. Epub 2017 Nov 17.

9.

Letter by Vos et al Regarding Article, "Primary Prevention With Statin Therapy in the Elderly: New Meta-Analyses From the Contemporary JUPITER and HOPE-3 Randomized Trials".

Vos E, Biron P, Rose CP.

Circulation. 2017 Oct 10;136(15):1454-1455. doi: 10.1161/CIRCULATIONAHA.117.029008. No abstract available.

PMID:
28993376
10.

The design, production and clinical application of 3D patient-specific implants with drilling guides for acetabular surgery.

Merema BJ, Kraeima J, Ten Duis K, Wendt KW, Warta R, Vos E, Schepers RH, Witjes MJH, IJpma FFA.

Injury. 2017 Nov;48(11):2540-2547. doi: 10.1016/j.injury.2017.08.059. Epub 2017 Aug 30.

PMID:
28899562
11.

When and Why Statins Fail to Save Lives.

Vos E, Nguyen PV, Biron P, Rose CP.

Am J Med. 2017 Sep;130(9):e427. doi: 10.1016/j.amjmed.2017.02.037. No abstract available.

PMID:
28838741
12.

Focally positive margins in breast conserving surgery: Predictors, residual disease, and local recurrence.

Vos EL, Gaal J, Verhoef C, Brouwer K, van Deurzen CHM, Koppert LB.

Eur J Surg Oncol. 2017 Oct;43(10):1846-1854. doi: 10.1016/j.ejso.2017.06.007. Epub 2017 Jun 23.

PMID:
28688723
13.

TUmor-volume to breast-volume RAtio for improving COSmetic results in breast cancer patients (TURACOS); a randomized controlled trial.

Lagendijk M, Vos EL, Koning AHJ, Hunink MGM, Pignol JP, Corten EML, de Monye C, van Deurzen CHM, van Dam JH, Vrijland WW, Contant CME, Verhoef C, van Lankeren W, Koppert LB.

BMC Cancer. 2017 May 17;17(1):336. doi: 10.1186/s12885-017-3280-y.

14.

Omitting re-excision for focally positive margins after breast-conserving surgery does not impair disease-free and overall survival.

Vos EL, Siesling S, Baaijens MHA, Verhoef C, Jager A, Voogd AC, Koppert LB.

Breast Cancer Res Treat. 2017 Jul;164(1):157-167. doi: 10.1007/s10549-017-4232-6. Epub 2017 Apr 7.

15.

Spontaneous Hemoperitoneum from Rupture of Massive Leiomyoma.

Schwitkis A, Shen S, Vos E, Torbati SS.

Clin Pract Cases Emerg Med. 2017 Mar 16;1(2):148-149. doi: 10.5811/cpcem.2017.1.33190. eCollection 2017 May. No abstract available.

16.

Enhancer-Mediated Oncogenic Function of the Menin Tumor Suppressor in Breast Cancer.

Dreijerink KMA, Groner AC, Vos ESM, Font-Tello A, Gu L, Chi D, Reyes J, Cook J, Lim E, Lin CY, de Laat W, Rao PK, Long HW, Brown M.

Cell Rep. 2017 Mar 7;18(10):2359-2372. doi: 10.1016/j.celrep.2017.02.025.

17.

Stakeholder perspectives on the implementation of genetic carrier screening in a changing landscape.

Holtkamp KC, Vos EM, Rigter T, Lakeman P, Henneman L, Cornel MC.

BMC Health Serv Res. 2017 Feb 16;17(1):146. doi: 10.1186/s12913-017-2083-9.

18.

Subjective hearing impairment after subarachnoid haemorrhage: Prevalence and risk factors.

Vos EM, Greebe P, Visser-Meily JMA, Rinkel GJE, Vergouwen MDI.

J Neurol Sci. 2017 Jan 15;372:184-186. doi: 10.1016/j.jns.2016.11.062. Epub 2016 Nov 24.

PMID:
28017208
19.

Feasibility of Multiparametric Magnetic Resonance Imaging of the Prostate at 7 T.

Lagemaat MW, Philips BW, Vos EK, van Uden MJ, Fütterer JJ, Jenniskens SF, Scheenen TW, Maas MC.

Invest Radiol. 2017 May;52(5):295-301. doi: 10.1097/RLI.0000000000000342.

PMID:
28002239
20.
21.

Improving pentose fermentation by preventing ubiquitination of hexose transporters in Saccharomyces cerevisiae.

Nijland JG, Vos E, Shin HY, de Waal PP, Klaassen P, Driessen AJ.

Biotechnol Biofuels. 2016 Jul 26;9:158. doi: 10.1186/s13068-016-0573-3. eCollection 2016.

22.

Time Dependence of the Electron and Positron Components of the Cosmic Radiation Measured by the PAMELA Experiment between July 2006 and December 2015.

Adriani O, Barbarino GC, Bazilevskaya GA, Bellotti R, Boezio M, Bogomolov EA, Bongi M, Bonvicini V, Bottai S, Bruno A, Cafagna F, Campana D, Carlson P, Casolino M, Castellini G, De Santis C, Di Felice V, Galper AM, Karelin AV, Koldashov SV, Koldobskiy SA, Krutkov SY, Kvashnin AN, Leonov A, Malakhov V, Marcelli L, Martucci M, Mayorov AG, Menn W, Mergé M, Mikhailov VV, Mocchiutti E, Monaco A, Mori N, Munini R, Osteria G, Panico B, Papini P, Pearce M, Picozza P, Ricci M, Ricciarini SB, Simon M, Sparvoli R, Spillantini P, Stozhkov YI, Vacchi A, Vannuccini E, Vasilyev GI, Voronov SA, Yurkin YT, Zampa G, Zampa N, Potgieter MS, Vos EE.

Phys Rev Lett. 2016 Jun 17;116(24):241105. doi: 10.1103/PhysRevLett.116.241105. Epub 2016 Jun 17.

PMID:
27367381
23.

Validation of the Oral Survey-B System for Electronic Data Capture in National Oral Health Surveys.

Carvalho JC, Declerck D, De Vos E, Kellen J, Van Nieuwenhuysen JP, Vanobbergen J, Bottenberg P, Declerck C.

Caries Res. 2016;50(3):288-94. doi: 10.1159/000445446. Epub 2016 May 12.

PMID:
27170028
24.

The Effect of Rosuvastatin on Markers of Immune Activation in Treatment-Naive Human Immunodeficiency Virus-Patients.

Weijma RG, Vos ER, Ten Oever J, Van Schilfgaarde M, Dijksman LM, Van Der Ven A, Van Den Berk GE, Brinkman K, Frissen JP, Leyte A, Schouten IW, Netea MG, Blok WL.

Open Forum Infect Dis. 2015 Dec 23;3(1):ofv201. doi: 10.1093/ofid/ofv201. eCollection 2016 Jan.

25.

CTCF Binding Polarity Determines Chromatin Looping.

de Wit E, Vos ES, Holwerda SJ, Valdes-Quezada C, Verstegen MJ, Teunissen H, Splinter E, Wijchers PJ, Krijger PH, de Laat W.

Mol Cell. 2015 Nov 19;60(4):676-84. doi: 10.1016/j.molcel.2015.09.023. Epub 2015 Oct 29.

26.

Benefits of preoperative MRI in breast cancer surgery studied in a large population-based cancer registry.

Vos EL, Voogd AC, Verhoef C, Siesling S, Obdeijn IM, Koppert LB.

Br J Surg. 2015 Dec;102(13):1649-57. doi: 10.1002/bjs.9947. Epub 2015 Oct 8.

PMID:
26445887
27.

Patient Satisfaction and Nipple-Areola Sensitivity After Bilateral Prophylactic Mastectomy and Immediate Implant Breast Reconstruction in a High Breast Cancer Risk Population: Nipple-Sparing Mastectomy Versus Skin-Sparing Mastectomy.

van Verschuer VM, Mureau MA, Gopie JP, Vos EL, Verhoef C, Menke-Pluijmers MB, Koppert LB.

Ann Plast Surg. 2016 Aug;77(2):145-52. doi: 10.1097/SAP.0000000000000366.

PMID:
26076217
28.

Medical-Legal Strategies to Improve Infant Health Care: A Randomized Trial.

Sege R, Preer G, Morton SJ, Cabral H, Morakinyo O, Lee V, Abreu C, De Vos E, Kaplan-Sanoff M.

Pediatrics. 2015 Jul;136(1):97-106. doi: 10.1542/peds.2014-2955. Epub 2015 Jun 1.

29.

(1)H MR spectroscopic imaging of the prostate at 7T using spectral-spatial pulses.

Lagemaat MW, Breukels V, Vos EK, Kerr AB, van Uden MJ, Orzada S, Bitz AK, Maas MC, Scheenen TW.

Magn Reson Med. 2016 Mar;75(3):933-45. doi: 10.1002/mrm.25569. Epub 2015 May 6.

PMID:
25943445
30.

Multiparametric Magnetic Resonance Imaging for Discriminating Low-Grade From High-Grade Prostate Cancer.

Vos EK, Kobus T, Litjens GJ, Hambrock T, Hulsbergen-van de Kaa CA, Barentsz JO, Maas MC, Scheenen TW.

Invest Radiol. 2015 Aug;50(8):490-7. doi: 10.1097/RLI.0000000000000157.

PMID:
25867656
31.

Overall survival in patients with a re-excision following breast conserving surgery compared to those without in a large population-based cohort.

Vos EL, Jager A, Verhoef C, Voogd AC, Koppert LB.

Eur J Cancer. 2015 Feb;51(3):282-91. doi: 10.1016/j.ejca.2014.12.003. Epub 2014 Dec 27.

PMID:
25549530
32.

Calcific tendinitis of the longus colli muscle.

Torbati SS, Vos EM, Bral D, Geiderman JM, Broukhim B.

Ear Nose Throat J. 2014 Dec;93(12):492-3. No abstract available.

PMID:
25531841
33.

Preoperative prediction of cosmetic results in breast conserving surgery.

Vos EL, Koning AH, Obdeijn IM, van Verschuer VM, Verhoef C, van der Spek PJ, Menke-Pluijmers MB, Koppert LB.

J Surg Oncol. 2015 Feb;111(2):178-84. doi: 10.1002/jso.23782. Epub 2014 Oct 20.

PMID:
25332158
34.

Renal rupture following extracorporeal shockwave lithotripsy.

Torbati SS, Niku M, Vos E, Hogan S.

West J Emerg Med. 2014 Sep;15(6):706-7. doi: 10.5811/westjem.2014.9.22547.

35.

Intramucosal carcinoma of the rectum can be safely treated with transanal endoscopic microsurgery; clinical support of the revised Vienna classification.

Verseveld M, Barendse RM, Dawson I, Vos EL, de Graaf EJ, Doornebosch PG.

Surg Endosc. 2014 Nov;28(11):3210-5. doi: 10.1007/s00464-014-3593-8. Epub 2014 Jun 18.

PMID:
24939156
36.

Image quality and cancer visibility of T2-weighted magnetic resonance imaging of the prostate at 7 Tesla.

Vos EK, Lagemaat MW, Barentsz JO, Fütterer JJ, Zámecnik P, Roozen H, Orzada S, Bitz AK, Maas MC, Scheenen TW.

Eur Radiol. 2014 Aug;24(8):1950-8. doi: 10.1007/s00330-014-3234-6. Epub 2014 May 28.

PMID:
24865699
37.

[Curative resection of a solitary clavicular metastasis].

Vos E, Seynaeve C, Obdeijn IM, Mureau MA, Verhofstad MH, Rothbarth J.

Ned Tijdschr Geneeskd. 2014;158:A7296. Dutch.

PMID:
24823854
38.

(31) P MR spectroscopic imaging of the human prostate at 7 T: T1 relaxation times, Nuclear Overhauser Effect, and spectral characterization.

Lagemaat MW, Maas MC, Vos EK, Bitz AK, Orzada S, Weiland E, van Uden MJ, Kobus T, Heerschap A, Scheenen TW.

Magn Reson Med. 2015 Mar;73(3):909-20. doi: 10.1002/mrm.25209. Epub 2014 Mar 26.

PMID:
24677408
39.

Implementation of the nutrition and health claim regulation - the case of antioxidants.

de Boer A, Vos E, Bast A.

Regul Toxicol Pharmacol. 2014 Apr;68(3):475-87. doi: 10.1016/j.yrtph.2014.01.014. Epub 2014 Feb 10.

PMID:
24525062
40.

Phosphorus magnetic resonance spectroscopic imaging at 7 T in patients with prostate cancer.

Lagemaat MW, Vos EK, Maas MC, Bitz AK, Orzada S, van Uden MJ, Kobus T, Heerschap A, Scheenen TW.

Invest Radiol. 2014 May;49(5):363-72. doi: 10.1097/RLI.0000000000000012.

PMID:
24335715
41.

Woman with right lower quadrant mass and abdominal pain.

Torbati SS, Hogan S, Vos E, Banayan E.

J Emerg Med. 2014 Feb;46(2):220-2. doi: 10.1016/j.jemermed.2013.08.066. Epub 2013 Oct 15. No abstract available.

PMID:
24135503
42.

Solvent- and catalyst-free huisgen cycloaddition to rufinamide in flow with a greener, less expensive dipolarophile.

Borukhova S, Noël T, Metten B, de Vos E, Hessel V.

ChemSusChem. 2013 Dec;6(12):2220-5. doi: 10.1002/cssc.201300684. Epub 2013 Sep 23.

PMID:
24115350
43.

Clinical comparison between a currently available single-loop and an investigational dual-channel endorectal receive coil for prostate magnetic resonance imaging: a feasibility study at 1.5 and 3 T.

Vos EK, Sambandamurthy S, Kamel M, McKenney R, van Uden MJ, Hoeks CM, Yakar D, Scheenen TW, Fütterer JJ.

Invest Radiol. 2014 Jan;49(1):15-22. doi: 10.1097/RLI.0b013e3182a56678.

PMID:
24019020
44.

Feasibility of T2 -weighted turbo spin echo imaging of the human prostate at 7 tesla.

Maas MC, Vos EK, Lagemaat MW, Bitz AK, Orzada S, Kobus T, Kraff O, Maderwald S, Ladd ME, Scheenen TW.

Magn Reson Med. 2014 May;71(5):1711-9. doi: 10.1002/mrm.24818. Epub 2013 Jun 24.

PMID:
23798333
45.

Assessment of prostate cancer aggressiveness using dynamic contrast-enhanced magnetic resonance imaging at 3 T.

Vos EK, Litjens GJ, Kobus T, Hambrock T, Hulsbergen-van de Kaa CA, Barentsz JO, Huisman HJ, Scheenen TW.

Eur Urol. 2013 Sep;64(3):448-55. doi: 10.1016/j.eururo.2013.05.045. Epub 2013 May 31.

PMID:
23751135
46.

Point: why statins have failed to reduce mortality in just about anybody.

Vos E, Rose CP, Biron P.

J Clin Lipidol. 2013 May-Jun;7(3):222-4. doi: 10.1016/j.jacl.2013.01.007. Epub 2013 Feb 8. No abstract available.

PMID:
23725922
47.

Diffusion-weighted magnetic resonance imaging in the prostate transition zone: histopathological validation using magnetic resonance-guided biopsy specimens.

Hoeks CM, Vos EK, Bomers JG, Barentsz JO, Hulsbergen-van de Kaa CA, Scheenen TW.

Invest Radiol. 2013 Oct;48(10):693-701. doi: 10.1097/RLI.0b013e31828eeaf9.

PMID:
23614975
48.

Validation of the automated method VIENA: an accurate, precise, and robust measure of ventricular enlargement.

Vrenken H, Vos EK, van der Flier WM, Sluimer IC, Cover KS, Knol DL, Barkhof F.

Hum Brain Mapp. 2014 Apr;35(4):1101-10. doi: 10.1002/hbm.22237. Epub 2013 Jan 30.

PMID:
23362163
49.

Cognition decline and saturated fat intake link questioned: confounders missed.

Vos E.

Ann Neurol. 2012 Oct;72(4):626; author reply 626-7. doi: 10.1002/ana.23724. No abstract available.

PMID:
23109158
50.

Role of the intestinal microbiome in health and disease: from correlation to causation.

de Vos WM, de Vos EA.

Nutr Rev. 2012 Aug;70 Suppl 1:S45-56. doi: 10.1111/j.1753-4887.2012.00505.x. Review.

PMID:
22861807

Supplemental Content

Support Center